Showing results (21-30 of 212) with videos related to
Sort By:
Pageof 22
Molecular Cancer Therapeutics|November 9, 2005
PRL phosphatases as potential molecular targets in cancerBret J Stephens, Haiyong Han, Vijay Gokhale, et al.Critical Reviews in Oncogenesis|December 15, 2012
Tumor-stromal interactions in pancreatic cancerClifford Whatcott, Haiyong Han, Richard G Posner, et al.Nature Reviews. Cancer|September 24, 2011
Perineural invasion and associated pain in pancreatic cancerAditi A Bapat, Galen Hostetter, Daniel D Von Hoff, et al.Plos One|October 30, 2016
Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer CellsAditi A Bapat, Ruben M Munoz, Daniel D Von Hoff, et al.Molecular Cancer Therapeutics|June 19, 2003
Targeting Aurora-2 kinase in cancerSteven L Warner, David J Bearss, Haiyong Han, et al.American Journal of Clinical Oncology|April 7, 2009
Patient selection for phase II trialsGuru Sonpavde, Matthew D Galsky, Thomas E Hutson, et al.Seminars in Oncology|August 8, 2006
Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer elementLaurence H Hurley, Daniel D Von Hoff, Adam Siddiqui-Jain, et al.Molecular Cancer Therapeutics|January 12, 2008
Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cellsBret Stephens, Haiyong Han, Galen Hostetter, et al.Cancer Treatment and Research|June 19, 2019
Single-Cell Sequencing in Precision MedicineJulia E Wiedmeier, Pawan Noel, Wei Lin, et al.Molecular Cancer Therapeutics|July 24, 2014
Activation of Nrf2 pathways correlates with resistance of NSCLC cell lines to CBP501 in vitroNaoki Mine, Sayaka Yamamoto, Donald W Kufe, et al.Pageof 22